Skip to main content

Advertisement

SpringerLink
Log in

Chlorambucil-induced pulmonary disease: a case report and review of the literature

  • CASE REPORT
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

 A 77-year-old man developed pneumonitis while on chlorambucil therapy for chronic lymphocytic leukemia, with a cumulative dose of 2700 mg. The condition improved promptly with the discontinuation of the drug and initiation of steroids. A case report and review of the literature are presented in this paper.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Medicine Branch, National Cancer Institute, Bldg. 10, Room 12 N226, 9000 Rockville Pike, Bethesda, MD 20892, USA Tel.: 001 (301) 496-4916; Fax: 001 (301) 480-5181, , , , , , US

    H. T. Khong

  2. Hematology/Oncology Division, Baylor College of Medicine, 6565 Fannin, Houston, TX 77030, USA, , , , , , US

    J. McCarthy

Authors
  1. H. T. Khong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. McCarthy
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: September 9, 1997 / Accepted: March 31, 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khong, H., McCarthy, J. Chlorambucil-induced pulmonary disease: a case report and review of the literature. Ann Hematol 77, 85–87 (1998). https://doi.org/10.1007/s002770050418

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002770050418

Search

Navigation